FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006435712> ?p ?o ?g. }

• W2006435712 endingPage "107" @default.
• W2006435712 startingPage "107" @default.
• W2006435712 abstract "Update on the development of lurasidone as a treatment for patients with acute schizophrenia Norio Yasui-FurukoriDepartment of Neuropsychiatry, Hirosaki University School of Medicine, Aomori, JapanAbstract: Lurasidone is a novel benzisothiazole antipsychotic drug for the treatment of schizophrenia. Of the antipsychotic drugs, lurasidone has the highest affinity for the 5-hydroxytryptamine (5-HT)7 receptor. Lurasidone also has high affinities for the dopamine D2, 5HT2A, 5-HT1A and α2C adrenergic receptors. Moreover, lurasidone has low affinities for the α1 adrenergic, histamine H1 and muscarinic M1 receptors. The involvement of 5-HT7 receptors in cognitive processes has been suggested by both pharmacological and molecular investigations. Chronic treatment with lurasidone increases neurotrophin BDNF mRNA levels in both the hippocampus (ventral and dorsal) and prefrontal cortex under basal conditions or in response to an acute swim stress. Lurasidone may potentiate N-methyl-D-aspartate receptor (NMDAR) function through antagonistic action on 5-HT7 receptors without a direct affinity for NMDARs. These results suggest that lurasidone treatment may be a novel approach for the prevention of the development of cognitive impairment in individuals who are at risk for schizophrenia or related disorders involving cognitive impairment. In clinical trials, treatment with lurasidone was associated with significantly greater endpoint improvement versus placebo on the Positive and Negative Syndrome Scale total score after 6 weeks among subjects receiving 80 or 160 mg. The most frequent side effects of lurasidone were akathisia, nausea, parkinsonism, dizziness and somnolence. Once-daily treatment with lurasidone at 160 mg was superior to placebo based on the composite cognitive functioning measure. Lurasidone treatment produced improvements in Montgomery–Asberg Depression Rating Scale scores at 6 weeks that were significantly greater than placebo. A limitation of this review is that the majority of the data were obtained from abstracts and posters. These sources have not been subjected to the peer review processes of medical journals; thus, the results presented in these forums may require further quality review and subsequent revision prior to final publication.Keywords: lurasidone, antipsychotic, schizophrenia, 5-HT7, cognition, BDNF" @default.
• W2006435712 created "2016-06-24" @default.
• W2006435712 creator A5088581964 @default.
• W2006435712 date "2012-05-01" @default.
• W2006435712 modified "2023-10-14" @default.
• W2006435712 title "Update on the development of lurasidone as a treatment for patients with acute schizophrenia" @default.
• W2006435712 cites W1540394454 @default.
• W2006435712 cites W154276370 @default.
• W2006435712 cites W1616286551 @default.
• W2006435712 cites W1659384861 @default.
• W2006435712 cites W17057654 @default.
• W2006435712 cites W1839220452 @default.
• W2006435712 cites W1966819687 @default.
• W2006435712 cites W1967616469 @default.
• W2006435712 cites W1967834299 @default.
• W2006435712 cites W1969232587 @default.
• W2006435712 cites W1975950121 @default.
• W2006435712 cites W1979797229 @default.
• W2006435712 cites W1980719669 @default.
• W2006435712 cites W1981368038 @default.
• W2006435712 cites W1982585228 @default.
• W2006435712 cites W1992179353 @default.
• W2006435712 cites W1993236628 @default.
• W2006435712 cites W1993560189 @default.
• W2006435712 cites W1995362640 @default.
• W2006435712 cites W1996361061 @default.
• W2006435712 cites W2011773017 @default.
• W2006435712 cites W2019363012 @default.
• W2006435712 cites W2020995975 @default.
• W2006435712 cites W2022097360 @default.
• W2006435712 cites W2022808342 @default.
• W2006435712 cites W2023577040 @default.
• W2006435712 cites W2035261621 @default.
• W2006435712 cites W2043326331 @default.
• W2006435712 cites W2043973417 @default.
• W2006435712 cites W2046004431 @default.
• W2006435712 cites W2052262915 @default.
• W2006435712 cites W2053593733 @default.
• W2006435712 cites W2057430839 @default.
• W2006435712 cites W2058356149 @default.
• W2006435712 cites W2058362354 @default.
• W2006435712 cites W2059094743 @default.
• W2006435712 cites W2067757592 @default.
• W2006435712 cites W2075458285 @default.
• W2006435712 cites W2078053761 @default.
• W2006435712 cites W2091177718 @default.
• W2006435712 cites W2093431980 @default.
• W2006435712 cites W2098881037 @default.
• W2006435712 cites W2100557888 @default.
• W2006435712 cites W2104345556 @default.
• W2006435712 cites W2110652090 @default.
• W2006435712 cites W2110709054 @default.
• W2006435712 cites W2116679423 @default.
• W2006435712 cites W2117477487 @default.
• W2006435712 cites W2127115776 @default.
• W2006435712 cites W2137044087 @default.
• W2006435712 cites W2143080892 @default.
• W2006435712 cites W2147463028 @default.
• W2006435712 cites W2151331628 @default.
• W2006435712 cites W2153525031 @default.
• W2006435712 cites W2156436903 @default.
• W2006435712 cites W2162052901 @default.
• W2006435712 cites W2164534384 @default.
• W2006435712 cites W2167696061 @default.
• W2006435712 cites W2170792659 @default.
• W2006435712 cites W2307930405 @default.
• W2006435712 cites W2414538829 @default.
• W2006435712 cites W2604765914 @default.
• W2006435712 cites W2753974666 @default.
• W2006435712 cites W61969385 @default.
• W2006435712 cites W95266284 @default.
• W2006435712 cites W2098109122 @default.
• W2006435712 doi "https://doi.org/10.2147/dddt.s11180" @default.
• W2006435712 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3367402" @default.
• W2006435712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22675261" @default.
• W2006435712 hasPublicationYear "2012" @default.
• W2006435712 type Work @default.
• W2006435712 sameAs 2006435712 @default.
• W2006435712 citedByCount "15" @default.
• W2006435712 countsByYear W20064357122012 @default.
• W2006435712 countsByYear W20064357122013 @default.
• W2006435712 countsByYear W20064357122014 @default.
• W2006435712 countsByYear W20064357122016 @default.
• W2006435712 countsByYear W20064357122018 @default.
• W2006435712 countsByYear W20064357122020 @default.
• W2006435712 countsByYear W20064357122021 @default.
• W2006435712 countsByYear W20064357122022 @default.
• W2006435712 countsByYear W20064357122023 @default.
• W2006435712 crossrefType "journal-article" @default.
• W2006435712 hasAuthorship W2006435712A5088581964 @default.
• W2006435712 hasBestOaLocation W20064357121 @default.
• W2006435712 hasConcept C118552586 @default.
• W2006435712 hasConcept C126322002 @default.
• W2006435712 hasConcept C126855140 @default.
• W2006435712 hasConcept C15744967 @default.
• W2006435712 hasConcept C170493617 @default.
• W2006435712 hasConcept C2775864247 @default.
• W2006435712 hasConcept C2776412080 @default.

• next